-       Report 
   - May 2025
    -  120 Pages 
    Global
   
   From       €4269EUR$4,750USD£3,744GBP 
                -       Report 
   - August 2024
    -  110 Pages 
    Global
   
   From       €3550EUR$3,950USD£3,114GBP 
                -       Report 
   - October 2023
    -  74 Pages 
    Global
   
   From       €3500EUR$4,171USD£3,177GBP 
                      The Pneumonia Vaccine market is a subset of the larger Vaccines market. It is composed of vaccines that protect against the bacteria and viruses that cause pneumonia. These vaccines are typically administered to infants, children, and adults, and are recommended by the World Health Organization (WHO). The market is highly competitive, with a number of companies offering different types of vaccines.
The Pneumonia Vaccine market is driven by the increasing prevalence of the disease, as well as the    need for improved immunization coverage. Additionally, the development of new technologies and the introduction of new vaccines have also contributed to the growth of the market.
Some of the major companies in the Pneumonia Vaccine market include Merck & Co., GlaxoSmithKline, Pfizer, Sanofi, and AstraZeneca. These companies are involved in the development, manufacturing, and distribution of various types of pneumonia vaccines. Show Less   Read more